Q1 2022 13F Holders as of 3/31/2022
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
30.9M
-
Number of holders
-
262
-
Total 13F shares, excl. options
-
31.2M
-
Shares change
-
+404K
-
Total reported value, excl. options
-
$4.64B
-
Value change
-
+$60.2M
-
Put/Call ratio
-
3.62
-
Number of buys
-
116
-
Number of sells
-
-112
-
Price
-
$148.55
Significant Holders of CONMED Corp - Common Stock (CNMD) as of Q1 2022
287 filings reported holding CNMD - CONMED Corp - Common Stock as of Q1 2022.
CONMED Corp - Common Stock (CNMD) has 262 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 31.2M shares
.
Largest 10 shareholders include BlackRock Inc. (4.67M shares), VANGUARD GROUP INC (3.19M shares), EARNEST PARTNERS LLC (1.47M shares), Champlain Investment Partners, LLC (1.37M shares), AMERIPRISE FINANCIAL INC (1.23M shares), Capital Research Global Investors (1.14M shares), STATE STREET CORP (1.04M shares), JPMORGAN CHASE & CO (836K shares), LOOMIS SAYLES & CO L P (775K shares), and PRINCIPAL FINANCIAL GROUP INC (730K shares).
This table shows the top 262 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.